The Current Ratio as of November 2024 (TTM) for vTv Therapeutics Inc. (VTVT) is 6.61

According to vTv Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.61. This represents a change of 80.69% compared to the average of 3.66 of the last 4 quarters.

vTv Therapeutics Inc. (VTVT) Historical Current Ratio (quarterly & annually)

How has VTVT Current Ratio performed in the past?

The mean historical Current Ratio of vTv Therapeutics Inc. over the last ten years is 2.50. The current 6.61 Current Ratio has changed 26.38% with respect to the historical average. Over the past ten years (40 quarters), VTVT's Current Ratio was at its highest in in the September 2015 quarter at 16.10. The Current Ratio was at its lowest in in the September 2014 quarter at 0.

vTv Therapeutics Inc. (VTVT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of vTv Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

vTv Therapeutics Inc. (VTVT) Average Current Ratio

How has VTVT Current Ratio performed in the past?

The current Current Ratio of vTv Therapeutics Inc. (VTVT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

vTv Therapeutics Inc. (VTVT) Current Ratio vs. Peers

How is VTVT’s Current Ratio compared to its peers?

vTv Therapeutics Inc.’s Current Ratio is less than Zura Bio Limited (12.57), greater than Apexigen, Inc. (0.82), greater than Phio Pharmaceuticals Corp. (3.47), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Immix Biopharma, Inc. (7.00), greater than Sigilon Therapeutics, Inc. (1.78), greater than NovaBay Pharmaceuticals, Inc. (0.62), greater than InMed Pharmaceuticals Inc. (4.41), greater than GeoVax Labs, Inc. (0.60), less than Generation Bio Co. (7.42), less than Kronos Bio, Inc. (8.49), less than Erasca, Inc. (16.79), greater than C4 Therapeutics, Inc. (6.31), less than Edgewise Therapeutics, Inc. (30.24), greater than Allarity Therapeutics, Inc. (2.01), greater than NeuroBo Pharmaceuticals, Inc. (2.94), greater than Hillstream BioPharma, Inc. (2.25), less than Virax Biolabs Group Limited (25.94), greater than Quoin Pharmaceuticals, Ltd. (3.35), less than Pyxis Oncology, Inc. (9.53), greater than Altamira Therapeutics Ltd. (1.38), less than Elevation Oncology, Inc. (41.10),

Build a custom stock screener for vTv Therapeutics Inc. (VTVT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like vTv Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

vTv Therapeutics Inc. (VTVT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like vTv Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.